Financial Challenges of Cancer Survivorship: A Call for Policy Change
Marielle Santos McLeod continues to face significant financial challenges due to the costs associated with her colon cancer treatment, despite being in remission. Diagnosed in 2017, McLeod is still addressing outstanding chemotherapy bills and managing substantial out-of-pocket expenses for ongoing care monitoring, including specialist appointments. These financial burdens have led her to delay necessary medical scans and consultations, prioritizing her health spending amid high costs.
McLeod’s situation reflects a broader issue affecting nearly 19 million cancer survivors in the United States, who often require continuous medical attention post-recovery. A 2024 survey by the American Cancer Society Cancer Action Network involving over 1,200 cancer patients and survivors found that nearly half carried medical debts exceeding $5,000. This ongoing financial strain underscores challenges within health coverage and policy, particularly concerning high-deductible health plans requiring substantial initial out-of-pocket spending before insurer coverage begins.
Current proposals aimed at lowering insurance premiums emphasize flexibility in plan options but face criticism for potentially excluding necessary coverage for those with preexisting conditions, such as cancer. Michael Cannon of the Cato Institute advocates for increased consumer control over insurance choices by allowing plans exempt from specific ACA regulations. However, Jennifer Hoque from the American Cancer Society Cancer Action Network cautions against allowing insurers to reject applicants with preexisting conditions, emphasizing historical difficulties in obtaining coverage for these groups.
Veronika Panagiotou's experience further illustrates the complexities of insurance and financial management post-cancer diagnosis. Initially facing coverage denial due to her BMI, she was treated for non-Hodgkin lymphoma while uninsured in 2013. The introduction of ACA plans in 2014 allowed her to access necessary treatments, but the financial implications of her care continue to influence her decision-making even now.
The American Health Insurance Plans (AHIP) association acknowledges pressures from rising healthcare costs, attributing coverage challenges to increasing prices set by providers and manufacturers. Brian Blase of the Paragon Health Institute notes the necessity of addressing fundamental care costs, while efforts under the Inflation Reduction Act, including Medicare's drug price negotiation, aim to alleviate some financial burdens. Yet, efforts to reduce ACA protections could create additional hurdles for cancer survivors sustaining coverage amid life transitions.
Economic analyses project a rise in cancer-related care costs to $246 billion by 2030. While advancements in cancer treatment and detection increase survival rates, financial implications necessitate more comprehensive solutions to ensure access to essential post-recovery care. Ezekiel Emanuel from the University of Pennsylvania emphasizes that financial strains remain unresolved for survivors even after successful treatments. These discussions highlight ongoing challenges within healthcare policy, insurance plan structuring, and the need for sustained attention to the affordability and accessibility of care for cancer survivors.